By Sheeba M. | June 16, 2026
SAFE Act Delays Push Federal Legalization Timeline to 2027
The timeline for the Secure and Fair Enforcement (SAFE) Act just shifted significantly. Senate leadership sources indicate that banking reform legislation is unlikely to reach a floor vote before late Q2 2027—a 12-month slip from optimistic forecasts made earlier this year.
Why the Delay?
Political bandwidth remains consumed by broader financial services reform. The SAFE Act, while bipartisan in support, is not commanding floor time urgency with higher-priority bills competing. Additionally, lobbying pressure from banks and credit card networks has created procedural friction.
The practical impact: state-licensed cannabis remains a banking wasteland for another 18+ months.
What This Means for Investors
The delay actually supports a bullish case for MSOs. Without federal banking access, state markets remain fragmented and concentrated. Operators with strong cash flow like Trulieve and Ayr Wellness have structural advantages—they’ve already built workarounds and don’t need federal help to be profitable.
For Canadian LPs, this means the U.S. opportunity window stays open longer. Canopy Growth and others have time to execute on U.S. partnerships and optionality positions without facing immediate federal competition.
Sources
- U.S. Congress – SAFE Act (S. 420) — Legislative tracking
- Politico — Capitol Hill reporting
Track cannabis stocks with the Weedstock Real-Time Tracker